Nano-X Imaging (NNOX) announced last night that it will demonstrate its technology Nanox.SOURCE and medical imaging system Nanox.ARC at RSNA 2020, which is being held November 29 through December 5 in Chicago.

"The demonstration will include a technology section elaborating on Nanox's first commercial-grade digital x-ray source followed by a live demonstration of the Nanox.ARC in a range of 2D and 3D medical imaging procedures," the company said in a statement. Shares of Nano-X Imaging are up 33%, or $7.93, to $31.90 in premarket trading.

Ran Poliakine, Chairman and Chief Executive Officer of Nanox, stated: "We are pleased to invite everyone to witness first-hand our technology and the Nanox.ARC at the RSNA. We have an ambitious goal of making medical imaging widely available on a global basis to promote preventive healthcare through early detection. Two-thirds of the world's population currently have no access to medical imaging, and we aim to improve this statistic. We look forward to this demonstration which will allow people to see the depth and validity of our technology."

Nano-X Imaging has been the subject of short reports from Citron Research and Muddy Waters Research.